logo
  

Rigel Pharmaceuticals Inc. Q1 Earnings Summary

Below are the earnings highlights for Rigel Pharmaceuticals Inc. (RIGL):

Earnings: -$27.45 million in Q1 vs. $39.50 million in the same period last year.
EPS: -$0.16 in Q1 vs. $0.22 in the same period last year.
Analysts projected -$0.14 per share
Revenue: $16.20 million in Q1 vs. $12.38 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT